Gram-Negative Bacterial Infections
"Gram-Negative Bacterial Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.
| Descriptor ID |
D016905
|
| MeSH Number(s) |
C01.252.400
|
| Concept/Terms |
Gram-Negative Bacterial Infections- Gram-Negative Bacterial Infections
- Gram Negative Bacterial Infections
- Infections, Gram-Negative Bacterial
- Bacterial Infection, Gram-Negative
- Gram-Negative Bacterial Infection
- Infection, Gram-Negative Bacterial
- Infections, Gram Negative Bacterial
- Bacterial Infections, Gram-Negative
- Bacterial Infections, Gram Negative
|
Below are MeSH descriptors whose meaning is more general than "Gram-Negative Bacterial Infections".
Below are MeSH descriptors whose meaning is more specific than "Gram-Negative Bacterial Infections".
This graph shows the total number of publications written about "Gram-Negative Bacterial Infections" by people in this website by year, and whether "Gram-Negative Bacterial Infections" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 2 | 1 | 3 |
| 2016 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gram-Negative Bacterial Infections" by people in Profiles.
-
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019 01; 39(1):10-39.
-
Comparative Pharmacokinetic Profiling of Different Polymyxin B Components. Antimicrob Agents Chemother. 2016 11; 60(11):6980-6982.
-
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis. 2015 Feb; 15(2):225-34.
-
Validation of a model to predict the risk of nephrotoxicity in patients receiving colistin. Antimicrob Agents Chemother. 2014 Nov; 58(11):6946-8.
-
Uptake of polymyxin B into renal cells. Antimicrob Agents Chemother. 2014 Jul; 58(7):4200-2.